Table:
begin	end	state
1	1628	non-cytoplasmic

Input:
>GFF2321
MNALTVASKDQFFEQLADAFAKKISKTEAKKISEFAKQHYAHIPLEELVSRRFADTYGAV
LAAWQFLQKRSAEETPVAVFNPDLESDGWQSTHTVVFILHPNIPFLIDSLRIAINHREIG
THSIQHSILQVNRDQNGKLEKLHTSKKKASGSDYEAFIVLEIDRHSNPEDLRDLEDTLQN
VLHEVRIAVSDFPVVTEKVNEILGELDNTTAGINEEQKEEARAFLEWLARDHFTFLGYDE
YDFAKDKSGMVVRRVENSELGILRVNNERPDRVRLNELPQRTRHEMTRSDDIFIFAKSAQ
RSRVHRPAYPDYIAVKKFNSKGEVVGERRFLGLYTARVYNERPDEIPLLRRKFQSVMKRS
GFLRDDYAGKELEQILTVYPRDELFQIEQDELLKVAKSILYIQERRRIELFLREDVYGQF
VTCLAFFPRDIYNTELRLKVEQVLVDRLGAEDVEFVTHFSESVLARVQFTIRVPQVENRQ
LPTAEIREKVIELAQSWRDGLSEALSEAWGEEQGNELYRLWAGGFPASYTDMFSPRRAAI
DLEHIASSANNHDLAMSFYRALEEDESTLHFKLFYPDEPLPLSDVMPIFDNLGFRVIGEH
PFEVIDRHNKTVWIHDFTLQAHQGTVVDIHRIRPIFEELFRRVWYGEAENDAFNRMLLSS
YMSWREIALLRTYARYMRQIRFSNSQTFISNTLVNHVELTRLLLEFFEIRFNPERYQSPG
KSQAAQQKLEIEFNAGLENVENLSEDRVLRLYLELIQATLRTNYYQHGESGGPKPYISVK
FDPSRIPDMPLPMPMFEIFVYSPRVEGVHLRGGKVARGGLRWSDRFEDYRTEILGLVKAQ
QVKNAVIVPVGAKGGFVAKRLPDPSDREAFQAEGIEAYKTFIRGLLDITDNLVDAGIAPP
ERVIRHDDDDHYLVVAADKGTATFSDIANGLAAEYGFWMGDAFASGGSNGYDHKKMGITA
RGAWVSVERHFREMGINPGLDEFTAIGIGDMGGDVFGNGMLCSEKTKLVAAFNHVHIFVD
PSPDPEKSYKERMRLFGLPRSAWTDYDSKLISKGGGVFSRNSKSIPVSPEMKKLLGIKSD
RVPPNMLISHILKAQVDLLWVGGIGTYVKAASESHSDVGDKANDGLRINGSDLRCKVVGE
GGNLGLTQLGRIEFALKGGRLNTDFIDNSGGVDCSDHEVNMKILLNRAVAMGDLTNKQRN
IMLEEMTDDVAELVLKNNYRQTQAISIASEDAATRLEEYRRLMNTFESEGKLNRALEFLP
DDETLSERKLDKKGLTRPELSVLISYVKGDLKQTLIDSTLPDDPLLAGEMYKVFPRDLTQ
KFSKELGEHQLRREIIATQIANDMVNHMGITFVERLNQSTGADAASIALAWIIARDVFRI
DNWWDRIEALDFHVSAQLQMELMQDLMRLMRRSVRWLLRNRRAELSIQHHMERFADSVWA
ITAGLPEYLGDQAKTTWEKRHQALVDAGLPSELASVVSGTGHLYSSLGIIEAHEASGMPL
KTVANLYYELGDRLDLNWFASAIASLQPGSHWQALARESFREDLDWQQRALTTGVLKLAD
KPEDVPACVEAWLSRHQQMIDRWKSMLSELKGVREPEYAMFSVALRELLDLAQSTMHQPH
AEVEVQTN

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server